v3.25.2
Earnings (Loss) Per Share (Tables)
 6 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of basic and diluted earnings per share.
(In millions, except share and per share data)Three Months Ended June 30,Six Months Ended June 30,
202520242025
2024
Numerator:
Numerator for EPS - continuing operations
Net loss from continuing operations$(89.3)$(33.8)$(247.5)$(62.2)
Less: Income from continuing operations attributed to non-controlling interests16.3 11.1 30.5 18.5 
Numerator for basic and diluted EPS from continuing operations attributable to Delek$(105.6)$(44.9)$(278.0)$(80.7)
Numerator for EPS - discontinued operations
(Loss) income from discontinued operations, including gain on sale of discontinued operations$(1.0)$8.8 $(1.4)$12.4 
Less: Income tax (benefit) expense(0.2)1.1 (0.3)1.5 
(Loss) income from discontinued operations, net of tax$(0.8)$7.7 $(1.1)$10.9 
Denominator:
Weighted average common shares outstanding (denominator for basic EPS)60,506,943 64,213,899 61,306,915 64,117,943 
Dilutive effect of stock-based awards— — — — 
Weighted average common shares outstanding, assuming dilution (denominator for diluted EPS)60,506,943 64,213,899 61,306,915 64,117,943 
EPS:
Basic loss per share:
Loss from continuing operations$(1.75)$(0.70)$(4.53)$(1.26)
(Loss) income from discontinued operations(0.01)0.12 (0.02)0.17 
Total basic loss per share$(1.76)$(0.58)$(4.55)$(1.09)
Diluted loss per share:
Loss from continuing operations$(1.75)$(0.70)$(4.53)$(1.26)
(Loss) income from discontinued operations(0.01)0.12 (0.02)0.17 
Total diluted loss per share$(1.76)$(0.58)$(4.55)$(1.09)
The following equity instruments were excluded from the diluted weighted average common shares outstanding because their effect would be anti-dilutive:
Antidilutive stock-based compensation (because average share price is less than exercise price)2,446,267 1,397,499 2,384,652 1,250,217 
Antidilutive due to loss507,043 664,225 471,261 660,263 
Total antidilutive stock-based compensation2,953,310 2,061,724 2,855,913 1,910,480